BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25774504)

  • 1. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia.
    Li C; Chen P; Vadasz B; Ma L; Zhou H; Lang S; Freedman J; Ni H
    Thromb Haemost; 2013 Dec; 110(6):1250-8. PubMed ID: 24067944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.
    Li C; Piran S; Chen P; Lang S; Zarpellon A; Jin JW; Zhu G; Reheman A; van der Wal DE; Simpson EK; Ni R; Gross PL; Ware J; Ruggeri ZM; Freedman J; Ni H
    J Clin Invest; 2011 Nov; 121(11):4537-47. PubMed ID: 22019589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB; Vander Haar EL; Berkowitz RL
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
    Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
    Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody.
    Mørtberg TV; Zhi H; Vidarsson G; Foss S; Lissenberg-Thunnissen S; Wuhrer M; Michaelsen TE; Skogen B; Stuge TB; Andersen JT; Newman PJ; Ahlen MT
    Immunohorizons; 2022 Jan; 6(1):90-103. PubMed ID: 35074850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human antibodies targeting human platelet antigen (HPA)-1a.
    Oosterhoff JJ; Linty F; Visser R; de Vos T; Hofstede-van Egmond S; van de Weerd M; Porcelijn L; de Haas M; van der Schoot E; Vidarsson G
    Transfusion; 2024 May; 64(5):893-905. PubMed ID: 38400657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.
    Chen P; Li C; Lang S; Zhu G; Reheman A; Spring CM; Freedman J; Ni H
    Blood; 2010 Nov; 116(18):3660-8. PubMed ID: 20647570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal and neonatal alloimmune thrombocytopenia.
    Zdravic D; Yougbare I; Vadasz B; Li C; Marshall AH; Chen P; Kjeldsen-Kragh J; Ni H
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):19-27. PubMed ID: 26810319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.
    Stafford P; Ghevaert C; Campbell K; Proulx C; Smith G; Williamson LM; Ranasinghe E; Watkins NA; Huntington JA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):366-75. PubMed ID: 18045240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
    Salomon O; Rosenberg N
    Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells.
    Radder CM; Beekhuizen H; Kanhai HH; Brand A
    Clin Exp Immunol; 2004 Jul; 137(1):216-22. PubMed ID: 15196265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation].
    Petermann R
    Transfus Clin Biol; 2017 Sep; 24(3):166-171. PubMed ID: 28673503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.